Helping Patients With HR+/HER- Breast Cancer Access Abemaciclib

Experts explain the challenges patients with HR+/HER- breast cancer face in accessing abemaciclib for treatment and the options available such as patient assistance programs for high co-pays.

Related Keywords

,Optimizing Treatment ,Multidisciplinary Approach ,Cancer Access ,Breast Cancer ,Abc ,Hr Breast Cancer ,Her2 Breast Cancer ,Hr Her2 Breast Cancer ,Her2 Negative Breast Cancer ,Hr Positive Breast Cancer ,Breast Cancer Treatments ,Breast Cancer Therapies ,Multidisciplinary Care ,Medical Oncologists ,Radiation Oncologists ,Surgeons ,Pharmacists ,